Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation

Annals of Thoracic Surgery

Volumn 86, Issue 6, 2008, Pages 1841-1848

  Guo, Changfa ^a   Haider, Husnain Kh ^b   Wang, Chunsheng ^a   Tan, Ru San ^c   Shim, Winston S N ^c,d   Wong, Philip ^c   Sim, Eugene K W ^d,e  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c DEPARTMENT OF CARDIOLOGY   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e Gleneagles JPMC Cardiac Center   (Brunei Darussalam)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL INFILTRATION; CELL KINETICS; CELL LABELING; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; GRAFT SURVIVAL; HEART FUNCTION; HEART INFARCTION; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MYOBLAST; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; TISSUE REPAIR;

ANIMALS; CELL TRANSPLANTATION; CYCLOSPORINS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REGENERATION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; VENTRICULAR REMODELING;

EID: 56049107883     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.08.038     Document Type: Article

References (23)

1. Menasche P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
2. Smits P.C., van Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42 (2003) 2063-2069
3. Pagani F.D., DerSimonian H., Zawadzka A., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41 (2003) 879-888
4. Chachques J.C., Herreros J., Trainini J., et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 95 Suppl (2004) 29-33
5. Menasché P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
6. Law P.K., Law D.M., Lu P., et al. Human myoblast genome therapy. J Geriatric Cardiol 3 (2006) 135-151
7. Guo C., Haider H.K.h., Shim W.S., et al. Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. J Thorac Cardiovasc Surg 134 (2007) 1332-1339
8. Smythe G.M., and Grounds M.D. Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: implications for myoblast transfer therapy. Cell Transplant 9 (2000) 379-393
9. Morris P.J. The immunobiology of cell transplantation. Transplant Proc 24 (1992) 2865
10. Reinecke H., Minami E., Poppa V., and Murry C.E. Evidence for fusion between cardiac and skeletal muscle cells. Circ Res 94 (2004) e56-e60
11. Ishida M., Tomita S., Nakatani T., et al. Acute effects of direct cell implantation into the heart: a pressure-volume study to analyze cardiac function. J Heart Lung Transplant 23 (2004) 881-888
12. Teng C.J., Luo J., Chiu R.C., and Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 132 (2006) 628-632
13. Aicher A., Brenner W., Zuhayra M., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107 (2003) 2134-2139
14. Suzuki K., Murtuza B., Beauchamp J.R., et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 18 (2004) 1153-1155
15. Skuk D., Caron N., Goulet M., et al. Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant 11 (2002) 671-681
16. Hodgetts S.I., Beilharz M.W., Scalzo A.A., and Grounds M.D. Why do cultured transplanted myoblasts die in vivo?. DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 9 (2000) 489-502
17. Deasy B.M., Qu-Peterson Z., Greenberger J.S., and Huard J. Mechanisms of muscle stem cell expansion with cytokines. Stem Cells 20 (2002) 50-60
18. Vaidya T.B., Rhodes S.J., Taparowsky E.J., and Konieczny S.F. Fibroblast growth factor and transforming growth factor-β repress transcription of the myogenic regulatory gene MyoD1. Mol Cell Biol 9 (1989) 3576-3579
19. Yablonka-Reuveni Z., Balestreri T.M., and Bowen-Pope D.F. Regulation of proliferation and differentiation of myoblasts derived from adult mouse skeletal muscle by specific isoforms of PDGF. J Cell Biol 111 (1990) 1623-1629
20. Suzuki K., Brand N.J., Smolenski R.T., et al. Development of a novel method for cell transplantation through the coronary artery. Circulation 102 (2000) III359-III364
21. Suzuki K., Smolenski R.T., Jayakumar J., et al. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102 (2000) III216-III221
22. Zambrano J., Traverse J.H., Henry T., et al. The impact of intravenous allogeneic human mesenchymal stem cells (Provacel) on ejection fraction in patients with myocardial infarction. Circulation 116 Suppl (2007) II202
23. Pouzet B., Vilquin J.T., Hagege A.A., et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 71 (2001) 844-850